PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB...

Value in Health 2019 / 05 Vol. 22

PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL

Huynh, L., Wells, J.C., Graham, J., Steinharter, J., McGregor, B., Donskov, F., Bjarnason, G.A., Vaishampayan, U., Hansen, A., Iafolla, M., Zanotti, G., Chang, R., Cheng, W.Y., Duh, M.S., Heng, D.Y.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.146
Date:
May, 2019
File:
PDF, 653 KB
english, 2019
Conversion to is in progress
Conversion to is failed